Skip to main content

Xolair 150 mg lyophilized powder for injection Images

Generic Name: omalizumab

This medication has been identified as Xolair 150 mg lyophilized powder for injection. It is supplied by Genentech, Inc.

Xolair is used in the treatment of Urticaria; Nasal Polyps; Food Allergies; Asthma, Maintenance; Chronic Rhinosinusitis with Nasal Polyps and belongs to the drug class selective immunosuppressants. There is no proven risk in humans during pregnancy. Xolair 150 mg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Xolair 150 mg lyophilized powder for injection medicine

Xolair

Generic Name
omalizumab
Strength
150 mg lyophilized powder for injection
Availability
Prescription only
Drug Class
Selective immunosuppressants
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Genentech, Inc.
National Drug Code (NDC)
50242-0040

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.